INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
SEC FORM 4/Grant or awardVerified data

Abbott Richard David reported CODX

President · Co-Diagnostics, Inc. · Common Stock

Side
A
Value
—
Shares
56.7K
Price
—
Executed
Nov 23, 2025
Disclosed
Nov 24, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 23 executedNov 24, 2025 disclosed

CODX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
21/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 212.0% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CODX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    27
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Grant or award
    		A—
    1,890 sh
    		May 23, 2026May 27, 2026
    traded May 23, 2026
    		+4dSEC FORM 4

    Evidence

    23
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Disposition to issuer
    		D$3,448
    680 sh
    		May 23, 2026May 27, 2026
    traded May 23, 2026
    		+4dSEC FORM 4

    Evidence

    23
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Option exercise
    		M—
    1,890 sh
    		May 23, 2026May 27, 2026
    traded May 23, 2026
    		+4dSEC FORM 4

    Evidence

    17
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Disposition to issuer
    		D$6,020
    17.2K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    17
    AD
    Abbott Richard DavidPresident
    CODXCo-Diagnostics, Inc.
    Option exercise
    		M—
    56.7K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    17
    BL
    Brown Brian LeeChief Financial Officer
    CODXCo-Diagnostics, Inc.
    Grant or award
    		A—
    134.2K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    13
    BL
    Brown Brian LeeChief Financial Officer
    CODXCo-Diagnostics, Inc.
    Disposition to issuer
    		D$14K
    40.7K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    21
    BL
    Brown Brian LeeChief Financial Officer
    CODXCo-Diagnostics, Inc.
    Option exercise
    		M—
    134.2K sh
    		Nov 23, 2025Nov 24, 2025
    traded Nov 23, 2025
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002016256-25-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 23, 2025
    Published
    Nov 24, 2025
    Ingested by INSIDER
    Nov 5, 04:31 UTC
    Last re-read
    Nov 5, 04:31 UTC

    Extracted facts

    Filer
    Abbott Richard David
    Role
    President
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Co-Diagnostics, Inc.
    Ticker
    CODX
    Shares
    56.7K
    Price per share
    $0
    Execution date (reported)
    Nov 23, 2025
    Owned after transaction
    83.4K shares
    Days from execution to publication
    1

    What this establishes

    Abbott Richard David filed this Form 4 reporting a grant or award of CODX on Nov 23, 2025. It became public on Nov 24, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    President
    Abbott Richard Davidcik:0002016256
    Issuer
    Co-Diagnostics, Inc.cik:0001692415

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.

    Data sources
    SEC FORM 47m ago
    HOUSE PTR6m ago
    SEC 13F6m ago
    ROBINHOOD CHAIN6m ago